Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: Prospective randomized controlled trial

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue 6, 2006, Pages 1048-1053

  Murakami, Kazunari ^a   Sato, Ryugo ^a   Okimoto, Tadayoshi ^a   Watanabe, Koichiro ^a   Nasu, Masaru ^a   Kodama, Masaaki ^a   Fujioka, Toshio ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Eradication therapy; Helicobacter pylori; Maintenance therapy; Ulcer recurrence

Indexed keywords

AMOXICILLIN; CIMETIDINE; CLARITHROMYCIN; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DUODENUM ULCER; ERADICATION THERAPY; FEMALE; HELICOBACTER PYLORI; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; STOMACH ULCER;

EID: 33744742332     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2005.04038.x     Document Type: Article

References (25)

1. Asaka M Satoh K Sugano K et al. Guidelines in the management of Helicobacter pylori infection in Japan. Helicobacter 2001 6:177 86.
2. van der Hulst RWM Rauws EAJ Koych B et al. Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study. Gastroenterology 1997 113:1082 6.
3. Klein PD Malaty HM Martin RF et al. Noninvasive detection of Helicobacter pylori in clinical practice: the 13C urea breath test. Am. J. Gastroenterol. 1996 91:690 4.
4. Chey WD Spybrook M Carpenter S et al. Prolonged effect of omeprazole on the 14C-urea breath test. Am. J. Gastroenterol. 1996 91:89 92.
5. El-Nujumi A Hilditch TE Wiliams C et al. Current or recent proton pump inhibitor therapy markedly impairs the accuracy of the 14C-urea breath test. Eur J. Gastroenterol. Hepatol. 1998 10:759 64.
6. Laine L Estrada R Trojillo M et al. Effect of proton pump inhibitor therapy on diagnostic testing for Helicobacter pylori. Ann. Intern. Med. 1998 129:547 50.
7. Savarino V Bisso G Pivari M et al. Effect of gastric acid suppression on 13C-urea breath test: comparison of ranitidine with omeprazole. Aliment. Pharmacol. Ther. 2000 14:291 7.
8. Murakami K Sato R Okimoto T et al. Influence of anti-ulcer drugs in Japan on the result of 13C-urea breath test for the diagnosis of Helicobacter pylori infection. J. Gastroenterol. 2003 38:937 41.
9. NIH consensus conference; Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 1994 272:65 9.
10. Malfertiner P Megraud F O'Morain C et al. The European Helicobacter pylori Study Group. Current concepts in the management of H. pylori infection: The Maastricht 2-2000 Consensus Report. Aliment Phrmacol. Ther. 2002 16:167 80.
11. Sung JJ Chung SC Ling TK et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N. Engl. J. Med. 1995 19:139 42.
12. Logan RP Gummett PA Misiewicz JJ et al. One week's anti-Helicobacter pylori treatment for duodenal ulcer. Gut 1994 35:15 18.
13. Jyotheeswaren S Shah AN Jin HO et al. Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester NY: is empirical triple therapy justified? Am. J. Gastroenterol. 1998 93:574 8.
14. Laine L Hopikins RJ Girardi LS. Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials. Am. J. Gastroenterol. 1998 93:1409 15.
15. Liu CC Lee CL Chan CC et al. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer. Arch. Intern. Med. 2003 163:2020 4.
16. Yasunaga Y Shinomura Y Kanayama S et al. Improved fold width and increased acid secretion after eradication of the organism in Helicobacter pylori associated enlarged fold gastritis. Gut 1994 35:1571 4.
17. Guttierrez O Melo M Segura AM et al. Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis. Scand. J. Gastroenterol. 1997 32:664 8.
18. El-Omar EM Oien K El-nujumi A et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997 113:15 24.
19. Harris AW Gummett PA Phull PS et al. Recurrence of duodenal ulcer after Helicobacter pylori eradication is related to high acid output. Aliment Pharmacol. Ther. 1997 11:331 4.
20. Genta RM Lew GM Graham DY. Changes in the gastric mucosa following eradication of Helicobacter pylori. Mod. Pathol. 1993 6:281 9.
21. Hosking SW Ling TK Chung SC et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomized controlled trial. Lancet 1994 343:508 10.
22. Goh KL Navaratnam P Peh SC et al. Helicobacter pylori eradication with short-term therapy leads to duodenal ulcer healing without the need for continued acid suppression therapy. Eur. J. Gastroenterol. Hepatol. 1996 8:421 3.
23. Murakami K Fujioka T Okimoto T et al. Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy. Int. J. Antimicrob. Agents 2002 19:67 70.
24. Alarcon T Domingo D Lopez-Brea M. Antibiotic resistance problems with Helicobacter pylori. Int. J. Antimicrob. Agents 1999 12:19 26.
25. Murakami K Sato R Okimoto T et al. Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin. Aliment Pharmacol. Ther. 2002 16:1933 8.